{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-125393","form_type":"8-K","ticker":"RKDA","cik":"0001469443","company_name":"Arcadia Biosciences, Inc.","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.528702+00:00","generated_at":"2026-05-30T01:45:04.054690+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Arcadia Biosciences Q3 revenue up 18% to $1.5M; net loss narrows to $1.6M","bullets":["Total revenues $1.537M, +18% YoY; Zola coconut water revenue +55% YoY.","Zola retail distribution expanded 68% vs Q3 2023.","Net loss attributable to common stockholders $1.612M ($1.18/share) vs $2.567M ($1.89) in Q3 2023.","Operating expenses increased 22% to $3.297M due to higher revenues and severance costs.","Cash and cash equivalents $3.936M, down from $6.518M at Dec 31, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-125393","json":"https://secwatch.observer/filing/0000950170-24-125393.json","markdown":"https://secwatch.observer/filing/0000950170-24-125393.md","text":"https://secwatch.observer/filing/0000950170-24-125393.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1469443/000095017024125393/0000950170-24-125393-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1469443/000095017024125393/rkda-20241112.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T01:45:04.054690+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}